Autres langues Inhibrx, Inc.

Actions

INBX

US45720L1070

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
13,91 ^USD	-3,47 %		+7,25 %	-63,39 %

04/06	Un initié d'Inhibrx Biosciences a acheté des actions d'une valeur de 4 927 580 $, selon un récent dépôt auprès de la SEC	MT
30/05	Inhibrx, Inc. annonce des changements au sein de sa direction	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing	04/06
Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index	31/05
Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Global BMI Index	31/05
Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P TMI Index	31/05
Inhibrx, Inc. Announces Termination of Loan Agreement	30/05
Inhibrx, Inc. Announces Management Changes	30/05
Sanofi Closes Purchase of US Biotech Company Inhibrx	30/05
Sanofi : finalisation de l'acquisition d'Inhibrx	30/05
Sanofi/Inhibrx : Una situacion especial	30/05
Aventis Inc. completed the acquisition of Inhibrx, Inc. from a group of shareholders.	30/05
Inhibrx, Inc. completed the Spin-Off of 92% stake in Inhibrx Biosciences, Inc..	29/05
Inhibrx, Inc.(NasdaqGM:INBX) dropped from NASDAQ Biotechnology Index	29/05
Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi	24/05
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi	24/05
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off	11/05
Inhibrx : Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - Form 8-K	09/05
Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX	09/05
Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger	08/05
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - HMST, FREE, EVBG, INBX	27/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Inhibrx, Inc.

Actions

INBX

US45720L1070

Autres langues

Filtres